Patent waiver on vaccines: the ultimate remedy for COVID-19?
Guest:Zhang Qingkui, Former Head of the Department of Examination of Medical and
Patent
Patent waiver on vaccines: the ultimate remedy for COVID-19?
To view the whole show, please visit: http://www.chinaipmagazine.com/journal-show.asp?3697.html.
EU about COVID-19 vaccines: patent waiver, no; compulsory licensing, yes
The European Commission (EU) has finally taken a different route to solve the conumdrum posed by the COVID-19 vaccines from the US, which proposed to temporarily waive their patents early last month.
EPO becomes more friendly to Chinese patent applicants
On May 31, a decision of the President of EPO dated April 8, 2021 was announced exempting applicants claiming the priority of a first filing made in PRC from filing a copy of the search results under Rule 141(1) EPC – utilisation scheme.
1 billion yuan feud: General Protecht petitions against Gongniu Group
On Thursday, May 6, CNIPA issued a notice in General Protecht v. Gongniu Group in which the agency had accepted the petition filed by General Protecht for review of a decision in a patent infringement case against Gongniu Group in 2018.
